Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival von Halfdanarson, T.R., Rabe, K.G., Rubin, J., Petersen, G.M.

Volltext

Pembrolizumab induced bulbar myopathy and respiratory failure with necrotizing myositis of the diaphragm von Haddox, C.L., Shenoy, N., Shah, K.K., Kao, J.C., Jain, S., Halfdanarson, T.R., Wijdicks, E.F., Goetz, M.P.

Volltext

Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial von Welsh, J. L., Wagner, B. A., van’t Erve, T. J., Zehr, P. S., Berg, D. J., Halfdanarson, T. R., Yee, N. S., Bodeker, K. L., Du, J., Roberts, L. J., Drisko, J., Levine, M., Buettner, G. R., Cullen, J. J.

Volltext

Efficacy of ipilimumab and nivolumab in patients with high-grade neuroendocrine neoplasms von Al-Toubah, T., Halfdanarson, T., Gile, J., Morse, B., Sommerer, K., Strosberg, J.

Volltext

Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors von Halfdanarson, Thorvardur R, Rubin, Joseph, Farnell, Michael B, Grant, Clive S, Petersen, Gloria M

Volltext

A non-chemotherapy treatment of a primary effusion lymphoma: durable remission after intracavitary cidofovir in HIV negative PEL refractory to chemotherapy von Halfdanarson, TR, Markovic, SN, Kalokhe, U, Luppi, M

Volltext

Implementation of artificial intelligence (AI) for lung cancer clinical trial matching in a tertiary cancer center von Leventakos, K., Helgeson, J., Mansfield, A.S., Deering, E., Schwecke, A., Adjei, A., Molina, J., Hocum, C., Halfdanarson, T., Marks, R., Parikh, K., Pomerleau, K., Coverdill, S., Rammage, M., Haddad, T.

Volltext

Immune-related adverse events: Comparison of melanoma and non-small cell lung cancer patients treated with anti-PD1 therapy von Duma, N., Azzouqa, A.-G., Yadav, S., Hoversten, K., Reed, C., Sitek, A.N., Lou, Y., Molina, J., Halfdanarson, T., Leventakos, K., Joseph, R.W., Manochakian, R., Dronca, R.

Volltext

Quantifying global costs of reliable green hydrogen von Freire Ordóñez, D, Ganzer, C, Halfdanarson, T, González Garay, A, Patrizio, P, Bardow, A, Guillén-Gosálbez, G, Shah, N, Mac Dowell, N

Volltext

P-100Phase IB study of sorafenib + evofosfamide in patients (pts) with advanced hepatocellular carcinoma (HCC) and renal cell carcinoma (RCC): NCCTG N1153 (Alliance) von Borad, M, Renfro, L, Foster, N, Martin, P, Alberts, S, Hubbard, J, Silva, A, Halfdanarson, T, Byrne, T, Erlichman, C

Volltext

Phase 1b/II study of cancer stemness inhibitor napabucasin in combination with FOLFIRI +/− bevacizumab (bev) in metastatic colorectal cancer (mCRC) patients (pts) von Bendell, J., Hubbard, J., O’Neil, B.H., Jonker, D., Starodub, A., Peyton, J., Pitot, H., Halfdanarson, T., Nadeau, B., Zubkus, J., Adesunloye, B., Edenfield, J., Li, Y.Z., Li, W., Grothey, A., Borodyansky, L., Li, C.J.

Volltext

Single Institutional Experience Using Radiation Therapy in the Treatment of Neuroendocrine Tumor Primary and Metastatic Lesions von Qualls, K.W., Schoffner, J., Dodoo, C.A., Gunn, H.J., Halfdanarson, T., Merrell, K.W., Haddock, M.G., Hallemeier, C.L., Jethwa, K.R.

Volltext

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium von Khaki, A.R., Wise-Draper, T.M., French, B., Hennessy, C., Hsu, C.-Y., Shyr, Y., Painter, C.A., Peters, S., Rini, B.I., Mishra, S., Rivera, D.R., Acoba, J.D., Bashir, B., Bekaii-Saab, T., Berg, S., Bernicker, E.H., Bilen, M.A., Bindal, P., Bishnoi, R., Bouganim, N., Bowles, D.W., Cabal, A., Caimi, P.F., Crowell, J., Desai, A., Dixon, B., Doroshow, D.B., Durbin, E.B., Farmakiotis, D., Fazio, A., Fecher, L.A., Friese, C.R., Fu, J., Gadgeel, S.M., Glover, M.J., Goyal, S., Grover, P., Gulati, S., Gupta, S., Halabi, S., Halfdanarson, T.R., Halmos, B., Hausrath, D.J., Hawley, J.E., Hsu, E., Jani, C., Jayaraj, A., Johnson, D.B., Kasi, A., Khan, H., Kuderer, N.M., Kwon, D.H., Li, A., Loaiza-Bonilla, A., Low, C.A., Lustberg, M.B., Lyman, G.H., McKay, R.R., McNair, C., Menon, H., Mesa, R.A., Mundt, D., Nagaraj, G., Nakasone, E.S., Nizam, A., Nock, N.L., Patel, J.M., Patel, K.G., Peddi, P., Pennell, N.A., Piper-Vallillo, A.J., Puc, M., Reeves, M.E., Reuben, D.Y., Rosovsky, R.P., Salazar, M., Schmidt, A.L., Schwartz, G.K., Shah, M.R., Shah, S.A., Shah, C., Shaya, J.A., Stockerl-Goldstein, K.E., Streckfuss, M., Subbiah, S., Tachiki, L., Thakkar, A., Tucker, M.D., Verma, A.K., Vinh, D.C., Weiss, M., Wu, J.T., Wulff-Burchfield, E., Xie, Z., Yu, P.P., Zhou, A.Y., Zhu, H., Zubiri, L., Warner, J.L., Lopes, GdL

Volltext

The impact of peptide receptor radionucleotide therapy with Lutetium-177 DOTATATE on cardiac metastases in neuroendocrine tumors von Scalia, I, Sonbol, B, Farina, J M, Pereyra, M, Wang, Y, Bekaii-Saab, T S, Yang, M, Connolly, H M, Pellikka, P A, Herrmann, J, Halfdanarson, T R, Starr, J S, Luis, A S, Arsanjani, R, Ayoub, C

Volltext

Extra-hepatic hepatocellular carcinoma presenting as obstructive jaundice von Batsis, J.A., Halfdanarson, T.R., Pitot, H.

Volltext

An Analysis of Primary Site Radiation, Surgery, and Survival in Metastatic Rectal Cancer: A National Cancer Database Population Study von Roberts, K., Arnett, A.L.H., Jethwa, K.R., Wilhite, T.J., Day, C.N., Halfdanarson, T., Hallemeier, C.L., Haddock, M.G., Merrell, K.W.

Volltext

Neoadjuvant chemotherapy switch allows for surgical salvage in borderline & locally advanced pancreatic cancer von Alva-Ruiz, R., Yonkus, J., Yohanathan, L., Gregory, L., Abdelrahman, A., Grotz, T., Smoot, R., Cleary, S., Nagorney, D., Kendrick, M., Halfdanarson, T., McWilliams, R., Truty, M.

Volltext

200PImplementation of artificial intelligence (AI) for lung cancer clinical trial matching in a tertiary cancer center von Leventakos, K, Helgeson, J, Mansfield, A S, Deering, E, Schwecke, A, Adjei, A, Molina, J, Hocum, C, Halfdanarson, T, Marks, R, Parikh, K, Pomerleau, K, Coverdill, S, Rammage, M, Haddad, T

Volltext

Quantifying global costs of reliable green hydrogen von Ordonez, DF, Ganzer, C, Halfdanarson, T, Garay, AG, Patrizio, P, Bardow, A, Guillen-Gosalbez, G, Shah, N, Mac Dowell, N

Volltext

1218PImmune-related adverse events: Comparison of melanoma and non-small cell lung cancer patients treated with anti-PD1 therapy von Duma, N, Azzouqa, A-G, Yadav, S, Hoversten, K, Reed, C, Sitek, A N, Lou, Y, Molina, J, Halfdanarson, T, Leventakos, K, Joseph, R W, Manochakian, R, Dronca, R

Volltext